Patient-reported anticipated barriers and benefits to sharing cancer genetic risk information with family members.
Journal
European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
23
12
2020
accepted:
02
04
2021
revised:
22
03
2021
pubmed:
20
4
2021
medline:
24
3
2022
entrez:
19
4
2021
Statut:
ppublish
Résumé
While prior studies have largely focused on family communication of diagnostic single-gene test results or specific types of cancer testing results, far less work has investigated family communication of cancer-related genetic results that include multi-gene panels, a broad array of cancer types/stages, and participants without family history of cancer. The study we report here examined individuals' anticipated barriers and benefits to sharing genetic information with family members. An 80+ gene panel was performed on participants recruited from Mayo Clinic, diagnosed with different cancer types, who did not have a family history suggestive of an inherited risk. Participants completed a 49-item survey before receiving genetic test results. Family variant testing was provided to family members at no cost, allowing factors influencing intent to share to be examined in the absence of financial burdens. In all, 1721 of 2984 individuals who received genetic testing completed the survey (57.7% completion rate). Participants' intent to share with parents, siblings, and children was inversely related to the number of anticipated barriers to sharing and directly related to the number of anticipated benefits to sharing. Of those participants who did not intend to share with parents, siblings, and adult children, 64.8%, 30.3%, and 67.6% reported that there were no barriers, while 17.1%, 24.5%, and 40.2.% reported there were no benefits. Findings indicate that barriers to sharing genetic information with family members vary across family member types, and an inability to identify at least one benefit of sharing with family members is a predictor of intent not to share.
Identifiants
pubmed: 33867528
doi: 10.1038/s41431-021-00890-1
pii: 10.1038/s41431-021-00890-1
pmc: PMC8738729
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
53-61Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR002377
Pays : United States
Informations de copyright
© 2021. The Author(s), under exclusive licence to European Society of Human Genetics.
Références
Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Gastroenterology. 2014;147:502–26.
doi: 10.1053/j.gastro.2014.04.001
Li ST, Sun S, Lie D, Met‐Domestici M, Courtney E, Menon S, et al. Factors influencing the decision to share cancer genetic results among family members: an in‐depth interview study of women in an Asian setting. Psychooncology. 2018;27:998–1004.
doi: 10.1002/pon.4627
Nycum G, Avard D, Knoppers BM. Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information. Eur J Hum Genet. 2009;17:872–80.
doi: 10.1038/ejhg.2009.33
McCann S, MacAuley D, Barnett Y, Bunting B, Bradley A, Jeffers L, et al. Family communication, genetic testing and colonoscopy screening in hereditary non‐polyposis colon cancer: a qualitative study. Psychooncology. 2009;18:1208–15.
doi: 10.1002/pon.1487
Stuttgen K, Bollinger J, McCague A, Dvoskin R, Mathews D. Family communication patterns and challenges of huntington’s disease risk, the decision to pursue presymptomatic testing, and test results. J Huntingtons Dis. 2020;9:265–74.
Cheung EL, Olson AD, Tina MY, Han PZ, Beattie MS. Communication of BRCA results and family testing in 1,103 high-risk women. Cancer Epidemiol Biomarkers Prev. 2010;19:2211–9.
doi: 10.1158/1055-9965.EPI-10-0325
Conley CC, Ketcher D, Reblin M, Kasting ML, Cragun D, Kim J, et al. The big reveal: family disclosure patterns of BRCA genetic test results among young Black women with invasive breast cancer. J Genet Couns. 2020;29:410–22.
doi: 10.1002/jgc4.1196
Healey E, Taylor N, Greening S, Wakefield CE, Warwick L, Williams R, et al. Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families. Genet Med. 2017;19:1323–31.
doi: 10.1038/gim.2017.52
MacDonald DJ, Sarna L, van Servellen G, Bastani R, Giger JN, Weitzel JN. Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment. Genet Med. 2007;9:275–82.
doi: 10.1097/GIM.0b013e31804ec075
Forrest K, Simpson SA, Wilson BJ, Van Teijlingen ER, McKee L, Haites N, et al. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet. 2003;64:317–26.
doi: 10.1034/j.1399-0004.2003.00142.x
Foster C, Evans DG, Eeles R, Eccles D, Ashley S, Brooks L, et al. Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort. Genet Test. 2004;8:23–9.
doi: 10.1089/109065704323016003
Kinney AY, Gammon A, Coxworth J, Simonsen SE, Arce-Laretta M. Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. Genet Med. 2010;12:105–15.
doi: 10.1097/GIM.0b013e3181c9af2d
Samadder NJ, Riegert-Johnson D, Boardman L, Rhodes D, Wick M, Okuno S, et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. 2021;7:230–7.
Mesters I, Van Den Borne H, McCormick L, Pruyn J, De Boer M, Imbos T. Openness to discuss cancer in the nuclear family: scale, development, and validation. Psychosom Med. 1997;59:269–79.
doi: 10.1097/00006842-199705000-00010
Procidano ME, Heller K. Measures of perceived social support from friends and from family: three validation studies. Am J Community Psychol. 1983;11:1–24.
doi: 10.1007/BF00898416
Gaff CL, Clarke AJ, Atkinson P, Sivell S, Elwyn G, Iredale R, et al. Process and outcome in communication of genetic information within families: a systematic review. Eur J Hum Genet. 2007;15:999–1011.
doi: 10.1038/sj.ejhg.5201883
Claes E, Evers‐Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A. 2003;116:11–9.
doi: 10.1002/ajmg.a.10868
Stoffel EM, Ford B, Mercado RC, Punglia D, Kohlmann W, Conrad P, et al. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol. 2008;6:333–8.
doi: 10.1016/j.cgh.2007.12.014
Rowland E, Metcalfe A. Communicating inherited genetic risk between parent and child: a meta-thematic synthesis. Int J Nurs Stud. 2013;50:870–80.
doi: 10.1016/j.ijnurstu.2012.09.002
Tan KK, Lim TZ, Chan DK, Chew E, Chow WM, Luo N, et al. Getting the first degree relatives to screen for colorectal cancer is harder than it seems—patients’ and their first degree relatives’ perspectives. Int J Colorectal Dis. 2017;32:1065–8.
doi: 10.1007/s00384-017-2818-4
Chow-White P, Ha D, Laskin J. Knowledge, attitudes, and values among physicians working with clinical genomics: a survey of medical oncologists. Hum Resour Health. 2017;15:42.
doi: 10.1186/s12960-017-0218-z
Starkings R, Shilling V, Jenkins V, Fallowfield L. A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancer. Breast Cancer Res Treat. 2020;183:9–21.
Costalas JW, Itzen M, Malick J, Babb JS, Bove B, Godwin AK, et al. Communication of BRCA1 and BRCA2 results to at‐risk relatives: a cancer risk assessment program’s experience. Am J Med Genet C. 2003;119:11–8.
Hallowell N, Ardern‐Jones A, Eeles R, Foster C, Lucassen A, Moynihan C, et al. Communication about genetic testing in families of male BRCA1/2 carriers and non‐carriers: patterns, priorities and problems. Clin Genet. 2005;67:492–502.
doi: 10.1111/j.1399-0004.2005.00443.x
Aktan-Collan KI, Kääriäinen HA, Kolttola EM, Pylvänäinen K, Järvinen HJ, Haukkala AH, et al. Sharing genetic risk with next generation: mutation-positive parents’ communication with their offspring in Lynch syndrome. Fam Cancer. 2011;10:43–50.
doi: 10.1007/s10689-010-9386-x
Leenen CH, Den Heijer M, van der Meer C, Kuipers EJ, van Leerdam ME, Wagner A. Genetic testing for Lynch syndrome: family communication and motivation. Fam Cancer. 2016;15:63–73.
doi: 10.1007/s10689-015-9842-8